Literature DB >> 3950412

Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors.

H Müller, J Fehr.   

Abstract

The functional similarities between C-reactive protein (CRP) and IgG raised the question as to whether human phagocytes are stimulated by CRP in the same way as by binding of antigen-complexed or aggregated IgG to their Fc receptors. Studies with the use of highly purified 125I-labeled CRP showed specific and saturable binding to human polymorphonuclear leukocytes (PMN) with a KD of 10.5 +/- 5.7 X 10(-8) M only when carried out in heat-inactivated plasma. The number of specific binding sites per cell was estimated at 1 to 3 X 10(6). Competitive inhibition of CRP binding by antigen-complexed or aggregated IgG suggests CRP binding sites to be associated with PMN Fc receptors. Only when assayed in heat-inactivated plasma did CRP binding induce adherence of cells to tissue culture dishes. However, no metabolic and potentially cytotoxic stimulation of PMN was detected during CRP plasma-dependent attachment to surfaces: induction of aggregation, release of secondary granule constituents, and activation of the hexose monophosphate pathway were not observed. These results imply that CRP-PMN interactions is dependent on an additional factor present in heat-inactivated plasma and is followed only by a complement-independent increase in PMN attachment to surfaces. Because CRP was found to be deposited at sites of tissue injury, the CRP-mediated adherence of PMN may be an important step in localizing an inflammatory focus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950412

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.

Authors:  C Zouki; M Beauchamp; C Baron; J G Filep
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).

Authors:  Katherine B Bodman-Smith; Alirio J Melendez; Ian Campbell; Patrick T Harrison; Janet M Allen; John G Raynes
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

4.  C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.

Authors:  Jerome Denard; Beatrice Marolleau; Christine Jenny; Tata Nageswara Rao; Hans Jörg Fehling; Thomas Voit; Fedor Svinartchouk
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

Review 5.  C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 6.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 7.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

Review 8.  Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP.

Authors:  Sean P Mazer; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

9.  Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.

Authors:  L A Potempa; J M Zeller; B A Fiedel; C M Kinoshita; H Gewurz
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

Review 10.  Pattern recognition by pentraxins.

Authors:  Alok Agrawal; Prem Prakash Singh; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.